GS-2278 is an LPAR1 (lysophosphatidic acid receptor 1) antagonist with potential for research in idiopathic pulmonary fibrosis ( IPF ) [1].
References:
[1]. Kadunce N, et al. Early Process Development of an LPAR1 Antagonist, GS-2278[J]. Organic Process Research & Development, 2024.
References:
[1]. Kadunce N, et al. Early Process Development of an LPAR1 Antagonist, GS-2278[J]. Organic Process Research & Development, 2024.
















